# Conjugated Linoleic Acid / Leucine Versus Metformin on Visceral Fat in Metabolic Syndrome

> **NCT02629627** · PHASE2 · COMPLETED · sponsor: **Centro Universitario de Ciencias de la Salud, Mexico** · enrollment: 104 (actual)

## Conditions studied

- Metabolic Syndrome

## Interventions

- **DIETARY_SUPPLEMENT:** Conjugated linoleic acid/Leucine
- **DRUG:** Metformin
- **DIETARY_SUPPLEMENT:** Placebo of ACL/Leucine
- **OTHER:** Placebo of Metformin

## Key facts

- **NCT ID:** NCT02629627
- **Lead sponsor:** Centro Universitario de Ciencias de la Salud, Mexico
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2017-03
- **Final completion:** 2017-10
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2018-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02629627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02629627, "Conjugated Linoleic Acid / Leucine Versus Metformin on Visceral Fat in Metabolic Syndrome". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT02629627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*